⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TBPH News

Theravance Biopharma, Inc.

Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple System Atrophy